Elimination of Gender and Racial Differences in Recognition and Treatment of Patients at Risk for Su - PowerPoint PPT Presentation

1 / 15
About This Presentation
Title:

Elimination of Gender and Racial Differences in Recognition and Treatment of Patients at Risk for Su

Description:

Recent reports document gender and racial differences in the recognition and ... and scalability of CDS embedded into workflow across medical practices ... – PowerPoint PPT presentation

Number of Views:49
Avg rating:3.0/5.0
Slides: 16
Provided by: A1032
Category:

less

Transcript and Presenter's Notes

Title: Elimination of Gender and Racial Differences in Recognition and Treatment of Patients at Risk for Su


1
Elimination of Gender and Racial Differences in
Recognition and Treatment of Patients at Risk for
Sudden Cardiac Arrest
William Daniel, MD, FACC1,2 John Spertus, MD,
MPH, FACC2
  • 1Cardiovascular Consultants, Pennsylvania
  • 2Saint Lukes Mid America Heart Institute and
  • University of Missouri-Kansas City School of
    Medicine
  • Kansas City, Missouri

2
Background
  • Sudden cardiac arrest (SCA) is a leading cause of
    death in the United States.
  • ICDs can prevent SCA in high-risk patients.
  • Recent reports document gender and racial
    differences in the recognition and treatment of
    patients at risk for SCA.
  • Hernandez, et al (JAMA 2007) found lt 40 of
    potentially eligible patients hospitalized for
    heart failure received ICD therapy. Rates were
    lower among eligible women and black patients.
  • Novel solutions are needed to address this
    quality gap.
  • Altering the processes of outpatient care with
    flowsheets or electronic health records did not
    improve recognition in IMPROVE-HF.
  • In contrast, we previously reported the efficacy
    of a unique clinical decision support (CDS) tool
    to augment our EMR.
  • Recognition rates increased from 24 to 93 in a
    pre-/post- evaluation with concurrent controls.

3
Objective
  • To examine the impact of the CDS on gender and
    racial disparities in SCA recognition and
    treatment.

4
MethodsDevelopment of Clinical Decision Support
Tool (CDS)
5
Study Design
  • Recognition defined as at risk for SCA based on
    class I guidelines and referred for ICD or
    documented ICD implantation, patient refusal,
    patient no longer eligible for ICD, or temporary
    exclusion requiring further evaluation and
    treatment prior to consideration of ICD.
  • To establish the efficacy of the SCA recognition
    program, the intervention clinic was compared
    with 3 concurrent control clinics in a series of
    analyses as diagramed in the study timeline.

6
Study Timeline
7
Study Design
  • Analysis 1 The baseline SCA risk recognition and
    ICD implantation rate for men, women, and
    minorities was compared between the intervention
    clinic (prior to CDS) and the 3 control clinics
    to establish comparability at baseline.
  • Analysis 2 Pre/post comparison of the
    recognition for women and minorities after CDS
    implementation within the intervention clinic as
    compared with the control clinics.
  • Independent data collection and review of 6600
    medical charts for every patient in the active
    and control groups over a 2-month period from
    April-May 2006 was conducted.

8
Results
  • Analysis 1 Recognition and ICD implantation
    rates for men, women, and minorities at baseline,
    within each group, were similar in the
    intervention and control clinics.

9
Results
(CDS EMR)
10
Results
(CDS EMR)
11
Results
(CDS EMR)
12
Results
(CDS EMR)
13
Conclusions
  • This study demonstrates
  • That CDS improved recognition and ICD
    implantation rates overall
  • That gender and racial disparities which were
    present prior to CDS were no longer apparent
    afterwards
  • Widespread use of such objective CDS tools may
    reduce gender and racial disparities in treatment.

14
Limitations
  • Single practice setting - generalizability to
    other cardiologists and primary care physicians
    is unknown
  • Only addresses patients at highest risk based on
    LVEF and NYHA class

15
Future Directions
  • Demonstrate dissemination and scalability of CDS
    embedded into workflow across medical practices
    through multicenter trial/demonstration project
  • Develop clinical decision support to address
    other patients at risk for SCA
Write a Comment
User Comments (0)
About PowerShow.com